Anti-vascular endothelial growth factor (VEGF) therapies have revolutionized retinal disease treatment; however, VEGF signaling is only one component in the complex pathophysiology of retinal diseases (Fig. 1) [1–3]. The gene discussed is VEGFA; the disease is Abnormal retinal morphology.